Beam Therapeutics Inc. (BEAM) Nonoperating Income (Expense) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Beam Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2024.
  • Beam Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $5.46 M, a 121% increase year-over-year.
  • Beam Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $48.3 M, a 34.5% decline year-over-year.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $45.3 M, a 42.1% decline from 2022.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $78.3 M, a 259% increase from 2021.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $21.8 M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $48.3 M $5.46 M +$3 M +121% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $45.3 M $11.3 M -$40.3 M -78.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $85.7 M $12.2 M +$2.54 M +26.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $83.1 M $19.4 M +$9.36 M +93.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $73.8 M $2.47 M -$4.54 M -64.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $78.3 M $51.6 M +$52.9 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $25.4 M $9.64 M -$31.9 M -76.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $57.3 M $10 M +$27.3 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $30 M $7.01 M +$8.2 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $21.8 M -$1.22 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $41.5 M +$38.6 M +1347% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$17.3 M -$9.35 M -118% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1.19 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $2.87 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$7.93 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.